Metrovacesa revenue and financials

MVC · BME · EUR

Compare Metrovacesa
€11.32Change from previous close: −1.57%Absolute change: −€0.18

Close · November 20, 2026

In the fiscal year ended December 2025, Metrovacesa reported revenue of €708.37M (+8.47% year over year). Net income was €56.86M, a net margin of 8.0%.

Annual revenue · 2025: €708.37M
  1. €20.81M2016
  2. €28.36M2017
  3. €190.43M2018
  4. €161.3M2019
  5. €139.84M2020
  6. €512.1M2021
  7. €515.75M2022
  8. €580.62M2023
  9. €653.07M2024
  10. €708.37M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+8.47%
2025 vs 2024
Net income growth
+257.94%
2025 vs 2024
Net margin
8.0%
2024: 2.4%

How Metrovacesa is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue70865358151651214016119028.420.8
Cost of revenue52953045942240712114616611435.9
Gross profit18012312293.610519.115.124.8-85.5-15.1
Selling, general and administrative51.253.852.451.352.734.033.929.215.47.0
Operating income12676.165.235.857.5-20.2-7.81.4-73.9-30.0
EBIT12676.165.235.857.5-20.2-7.81.4-73.9-30.0
EBITDA12879.368.442.463.6-14.1-7.41.6-73.8—
Interest expense26.937.323.011.215.410.66.88.15.30.0
Pre-tax income72.524.5-16.5-18.323.7-157-2.40.4-78.1-19.7
Income tax15.78.64.35.25.36.12.19.5-39.20.8
Net income56.915.9-20.8-23.518.5-164-4.5-9.1-38.9-20.5
Net income to common shareholders56.915.9-20.8-23.518.5-164-4.5-9.1-38.9-20.5
Basic EPS0.380.10-0.14-0.160.12-1.08-0.03-0.03-0.44-0.30
Diluted EPS0.380.10-0.14-0.160.12-1.08-0.03-0.03-0.44-0.30
Average shares (basic)15215215115115115115133488.268.3
Average shares (diluted)15215215115115115115133488.268.3

Companies in the group: same industry, similar size